ABCC4 confer topoisomerase II inhibitor-resistance in macrophages and also serve as a critical member of the multidrug resistance-associated protein subfamily involved in efflux of anticancer/antiviral nucleotide agents inducing resistance to chemotherapy in several kinds of carcinomas [7]–[8]. The gene discussed is ABCC4; the disease is carcinoma.